In a chronic alcoholic patient with intermittent fever for six days and a new‑onset seizure, what is the most likely diagnosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Alcohol Withdrawal Syndrome with Seizures and Fever

The most likely diagnosis in this chronic alcoholic patient with intermittent fever for six days and new-onset seizures is alcohol withdrawal syndrome (AWS), though you must urgently rule out concurrent CNS infection (meningitis/encephalitis) or subacute encephalopathy with seizures in alcoholics (SESA syndrome).

Diagnostic Approach

Immediate Priorities

The clinical presentation demands simultaneous evaluation for three critical entities:

1. Alcohol Withdrawal Syndrome (AWS)

  • AWS typically develops 6-24 hours after the last drink, with seizures occurring within this early window 1
  • However, seizures can occur up to 48 hours post-cessation 2
  • The six-day fever timeline is atypical for uncomplicated AWS, raising concern for complications or alternative diagnoses
  • Assess using CIWA-Ar score: >8 indicates moderate AWS, ≥15 indicates severe AWS 1

2. CNS Infection (Critical to Exclude) Given the prolonged fever (6 days) with new seizures, you must actively exclude:

  • Bacterial meningitis: Obtain CSF analysis immediately if no contraindications
  • Encephalitis: Requires altered mental status >24 hours plus ≥2 of: documented fever ≥38°C, new focal findings, CSF WBC ≥5/mm³, abnormal neuroimaging, or EEG abnormalities 3
  • Chronic alcoholics have increased infection susceptibility

3. SESA Syndrome (Underrecognized)

  • Subacute encephalopathy with seizures in alcoholics presents with confusion, seizures, and focal deficits 4, 5, 6
  • Distinct from typical withdrawal seizures
  • Often manifests as non-convulsive status epilepticus (NCSE)
  • EEG shows periodic lateralized epileptiform discharges (PLEDs)
  • Requires continuous EEG monitoring for diagnosis 4

Critical Discriminating Features

Timing Analysis:

  • 6-48 hours post-drink: 83% of withdrawal seizures occur here 7
  • Beyond 72 hours: Only 17.7% of withdrawal cases; strongly suggests alternative etiology 7
  • Six-day fever: Highly atypical for uncomplicated AWS—demands infection workup

Laboratory Evaluation: Obtain immediately:

  • Blood glucose (hypoglycemia in 14-16% of alcohol-related seizures) 7
  • Electrolytes: sodium, potassium, magnesium (metabolic causes in 40% of non-withdrawal seizures) 7
  • Ketones/anion gap (alcoholic ketoacidosis in 16% of cases) 7
  • Blood cultures if febrile
  • Lumbar puncture if any concern for CNS infection

Neuroimaging:

  • CT head to exclude structural lesions, abscess, or hemorrhage
  • MRI with DWI if SESA suspected (shows reversible focal abnormalities) 5, 6

Management Algorithm

Immediate Treatment (Do Not Wait for Workup Completion)

For Seizure Control:

  • Benzodiazepines are first-line for AWS-related seizures 1
  • Long-acting agents (diazepam, chlordiazepoxide) provide better seizure protection
  • Use short-acting agents (lorazepam, oxazepam) if hepatic dysfunction present 1
  • Symptom-triggered regimen preferred over fixed dosing 1

If Seizures Persist (Refractory Status Epilepticus):

  • Administer additional antiepileptic after benzodiazepines 8
  • IV valproate: 79% effective as second-line (vs 25% for phenytoin), fewer adverse effects 8
  • Alternative options: levetiracetam, phenytoin/fosphenytoin, or barbiturates 8

For SESA/NCSE:

  • Requires aggressive antiepileptic therapy beyond typical AWS treatment 4, 5
  • IV valproate plus additional agents (lacosamide reported effective) 4
  • Continuous EEG monitoring mandatory 4, 6

Infection Management

If CNS infection suspected:

  • Start empiric antibiotics immediately (do not delay for LP if contraindicated)
  • Cover typical bacterial meningitis pathogens
  • Add acyclovir if encephalitis possible
  • Adjust based on CSF results

Common Pitfalls to Avoid

  1. Assuming all seizures in alcoholics are withdrawal-related: 62% of seizures in chronic alcoholics have non-withdrawal causes 7

  2. Missing SESA syndrome: Presents with confusion and focal deficits, easily mistaken for simple withdrawal 4, 5, 6

  3. Overlooking metabolic causes: Check glucose and electrolytes immediately—40% of non-withdrawal seizures have metabolic etiology 7

  4. Delaying infection workup: Six-day fever is NOT typical AWS—infection must be excluded

  5. Inadequate EEG monitoring: SESA often presents as NCSE requiring continuous EEG for diagnosis 4

Prognosis and Follow-up

  • 41.4% of patients with alcohol-related seizures develop epilepsy requiring long-term antiepileptic therapy 9
  • Risk factors for epilepsy development: multiple recurrent seizures, focal seizures, status epilepticus, abnormal EEG/imaging 9
  • SESA has good prognosis with appropriate treatment and full recovery expected 6
  • Overall mortality 2.4%, ICU admission 12% in alcohol-related seizure presentations 7

The six-day fever combined with new seizures in this chronic alcoholic mandates aggressive workup for CNS infection while simultaneously treating for AWS and monitoring for SESA syndrome with continuous EEG.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.